Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation.

Yang, Chang

Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation. [electronic resource] - Cancer discovery Feb 2013 - 212-23 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

2159-8290

10.1158/2159-8290.CD-12-0271 doi


Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
Blotting, Western
Bone Density Conservation Agents--adverse effects
Bone Neoplasms--metabolism
Bone and Bones--drug effects
Breast Neoplasms--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Cells, Cultured
Diphosphonates--administration & dosage
Humans
Imidazoles--administration & dosage
Inhibitor of Apoptosis Proteins--antagonists & inhibitors
Macrophages--cytology
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Nude
Molecular Structure
Oligopeptides--administration & dosage
Osteoclasts--cytology
Osteoporosis--chemically induced
Xenograft Model Antitumor Assays
Zoledronic Acid